The National Health and Medical Research Council (NHMRC) has advised that puberty blockers remain a clinical option for certain trans and gender-diverse children in Australia. However, Queensland and the Northern Territory both have rejected this advice, continuing to enforce their ban and restrictions on puberty blockers.
Puberty blockers, or Gonadotropin-releasing hormone analogues (GnRHa), are often prescribed to young people with gender dysphoria or gender incongruence, the medical term used for someone who experiences a difference between their gender and their sex at birth.
The treatment pauses aspects of physical development by suppressing sex hormones and is usually advised and recommended for people as an in-between waiting period as the individual decides whether to transition.
The NHMRC developed national guidelines for the care of trans and gender-diverse young people after Health Minister Mark Butler made the request in 2025, with a priority to be put on the use of puberty blockers.
The council used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the use of puberty blockers. This is a system based on the certainty of evidence on when a healthcare option should or should not be recommended.
GRADE approach is as follows:
Strongly for: When benefits clearly outweigh the harms. Recommended for most people.
Conditionally for: When benefits likely outweigh the harms. The best choice may depend on the individual patient.
Conditional for either option: When neither option is clearly better than the other. Either may be appropriate depending on the patient.
Conditionally against: When the harms likely outweigh the benefits, then treatment may be appropriate in some circumstances.
Strongly against: When the harms clearly outweigh the benefits, then treatment is generally not recommended.
View this post on Instagram
The Gender Guidelines Development Committee made a conditional recommendation for puberty blockers, meaning treatment may be appropriate depending on a young person’s individual circumstances and a shared decision between them, their carers and clinicians.
“A conditional recommendation is made in cases where shared decision-making is essential because different options may be appropriate for different individuals and they might make different choices, or where the overall certainty of available evidence is low. Both are the case here,” the report said.
While the committee acknowledged limited evidence, it found that puberty blockers may improve psychosocial functioning and reduce suicidal behaviours, with serious adverse events considered rare. The report also stated that puberty blockers “can affect the young person’s physical and mental health, wellbeing, and ability to function”.
It further recommended ongoing monitoring and highlighted gaps in research around fertility and bone health.
“Not all young people will want or need the same intervention at the same time or age, and care that is in one young person’s best interests may not suit another,” the report also noted.
However, the advice is not a legal requirement and remains just a suggestion. This allows Queensland and the Northern Territory to continue with their ban, and gives other states the choice of whether to implement the recommendations.
The Northern Territory banned the use of puberty blockers in the public system for people under 18, while last year saw Queensland become the first state in Australia to restrict access to GnRHa for children who were not already being given them in the public system.
Health Minister Mark Butler has said he expects all states and territories to regard the NHMRC’s advice.
“I’m very confident that every state government, no matter their political persuasion, will consider the advice of our pre-eminent authority very closely. Whether that will lead to a change of policy by either the Queensland or NT government is really a matter for them,” he said.
While the NHMRC’s recommendations do not guarantee changes to restrictions already in place, they provide welcomed guidance for the treatment of trans and gender diverse young people in Australia.
© 2026 GCN (Gay Community News). All rights reserved.
Support GCN
GCN is a free, vital resource for Ireland’s LGBTQ+ community since 1988.
GCN is a trading name of National LGBT Federation CLG, a registered charity - Charity Number: 20034580.
GCN relies on the generous support of the community and allies to sustain the crucial work that we do. Producing GCN is costly, and, in an industry which has been hugely impacted by rising costs, we need your support to help sustain and grow this vital resource.
Supporting GCN for as little as €1.99 per month will help us continue our work as Ireland’s free, independent LGBTQ+ media.